|
MechanismGABAA receptor positive allosteric modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Drawbridge Pharmaceuticals
0 Patents (Medical) associated with Drawbridge Pharmaceuticals
100 Deals associated with Drawbridge Pharmaceuticals
100 Translational Medicine associated with Drawbridge Pharmaceuticals